CompaniesCentus Biotherapeutics

Centus Biotherapeutics

defunct
About

Defunct Company

Areas of Focus

Categories

Bankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (1)
View all

Total Trials

1

As Lead Sponsor

1

As Collaborator

0

Total Enrollment

731

By Phase

PHASE3: 1

By Status

COMPLETED: 1
Clinical Trials Pipeline1 trial
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2015
2016
2017
2018
2019
2020
2021
2022
2023
Today
NCT02810457
Hover over trial bars to see details

Recent Trials

NCT02810457Lead Sponsor
Evaluation of FKB238 and Avastin in Patients With Advanced/Recurrent Non-squamous Non-small Cell Lung Cancer
PHASE3Completed
731 participants
Started: Sep 7, 2016 · Completed: Jan 26, 2022
Centus Biotherapeutics | Biotech Hunter | Biotech Hunter